Repli-Biom: a Novel Proteo-Genomic Approach to Identify Predictive Biomarkers of DDR Inhibitor Efficacy

Time: 11:30 am
day: Day Two


  • Repli-Biom combines proteomics, genomics, and synthetic lethality screens through computational approaches
  • Through this analysis, Repli-Biom identifies and prioritizes predictive biomarkers of drug sensitivity
  • This approach has now been used to identify novel biomarkers for ATR inhibitor treatments